1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Univariate analysis showing the association between hemorrhagic complications and the technical variables of patients treated by TVE
Variable Were There Hemorrhagic Complications? No (n = 49) Yes (n = 8) P Arterial balloon .39a Yes 11 3 No 38 5 No. of embolization sessions,(mean) (SD) 1.8 (1.2) 1.8 (0.99) .50b Coiled vein 1.0a Yes 15 2 No 34 6 Total occlusion (angiographic cure) 1.0a Yes 44 8 No 5 0
↵a Fisher exact test.
b Mann–Whitney test.